Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2010-022461-10-GB
EUCTR2010-022461-10-GB
Active, not recruiting
Not Applicable

A pilot study investigating the antiplatelet effect of generic clopidogrel versus Plavix™ – is there any difference in platelet reactivity in healthy subjects? - The effect of Plavix versus generic clopidogrel on platelet reactivity

Southampton University Hospitals NHS Trust0 sites15 target enrollmentNovember 2, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsThe intended indication for the product is for use in all patients with acute coronary syndromes and following coronary artery stenting
DrugsPlavix (Clopidogrel hydrogen sulphate)No trade name for this product.

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
The intended indication for the product is for use in all patients with acute coronary syndromes and following coronary artery stenting
Sponsor
Southampton University Hospitals NHS Trust
Enrollment
15
Status
Active, not recruiting
Last Updated
13 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 2, 2010
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Male

Investigators

Sponsor
Southampton University Hospitals NHS Trust

Eligibility Criteria

Inclusion Criteria

  • •Age \> 18 years
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Age \> 65 years
  • •Antiplatelet or non\-steroidal anti\-inflammatory medication administered within the previous 14 days
  • •Known clopidogrel intolerance
  • •Surgery planned within 4 weeks
  • •History of peptic ulceration or recent bleeding
  • •On regular prescribed medication

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
The effect of antiplatelet therapy after angioplasty.
EUCTR2016-002086-54-NLniversity Medical Center Utrecht1,806
Not yet recruiting
Not Applicable
A randomized trial of the effect of antiplatelet therapy (Aspirin, Aspirin and Clopidogrel or Ticagrelor) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty.antiplatelet therapy, peripheral transluminal angioplasty
NL-OMON28759Antonius Hospital Nieuwegein, Medisch Centrum Alkmaar.1,252
Completed
Phase 4
A randomized trial of the effect of antiplatelet therapy (Aspirin, Aspirin and Clopidogrel or Ticagrelor) on the occurrence of atherothrombotic events following lower extremity peripheral transluminal angioplasty.
NL-OMON47750niversitair Medisch Centrum Utrecht1,806
Recruiting
Phase 4
A randomized clinical trial of an antiplatelet agent in the treatment of acute stroke: cilostazol in the prevention of acute progressing stroke (CAPS) studyCerebral infarction
JPRN-UMIN000001630Tohoku Acute Progressing Stroke Study Group500
Completed
Not Applicable
A pilot study evaluating the effect of platelet transfusion using an electromechanical infusion pump versus conventional gravity flow methodPlatelet transfusionBlood - Haematological diseases
ACTRN12609000597291Clifford Craig Medical Trust Foundation240